SCHEMBL2213873

SCHEMBL2213873

COc1nccnc1-c1cnc(N2C[C@@H](C)O[C@@H](C)C2)c(C=O)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.40
GAK O14976 4/20 0.36
PIK3CA P42336 4/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
OPRK1 P41145 1/20 0.33
HPGD P15428 1/20 0.33
MDM2 Q00987 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515404 0.83 LRRK2 (0.45) LRRK2GAKKDM4EHTTTSHR
SCHEMBL2216042 0.81 GAK (0.41) LRRK2GAKPIK3CAKDM4EMTOR
SCHEMBL2247014 0.79 PIK3CA (0.40) GAKPIK3CAKDM4EHTTTSHR
SCHEMBL2247007 0.79 PIK3CA (0.40) GAKPIK3CAKDM4EHTTTSHR
SCHEMBL2214872 0.79 TDP1 (0.40) LRRK2GAKPIK3CAKDM4EHTT
SCHEMBL2215943 0.78 KDM4E (0.39) LRRK2GAKKDM4EHTTTSHR
SCHEMBL2214677 0.78 L3MBTL1 (0.36) GAKPIK3CAKDM4EMTORPIK3CD
SCHEMBL2215329 0.78 ERN1 (0.46) GAKKDM4EHTTTSHRALDH1A1
SCHEMBL2214152 0.78 LRRK2 (0.48) LRRK2GAKPIK3CAKDM4EHTT
SCHEMBL2214156 0.77 GAK (0.38) LRRK2GAKKDM4EHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL ASTRAZENECA R&D (SE) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL TBCA, TUBA1A, BROX LRRK2 414/4885GAK 1986/4885PIK3CA 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.